Top Markets
Coin of the day
Zhejiang Starry Pharmaceutical Co.,Ltd. Zhejiang Starry Pharmaceutical Co.,Ltd.

Zhejiang Starry Pharmaceutical Co.,Ltd.

603520
Rank in Stocks #12607
Founded in 1997 and headquartered in Xianju, China, Zhejiang Starry... Founded in 1997 and headquartered in Xianju, China, Zhejiang Starry Pharmaceutical Co.,Ltd. specializes in the research, production, and global distribution of X-CT non-ionic contrast agents and fluoroquinolone pharmaceuticals, along with their key intermediates. The company's extensive range of contrast agent products includes iohexol (and its hydrolysate and iodide derivatives), ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate. For fluoroquinolones, their offerings feature levofloxacin (and its hydrochloride salt), levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate.
Share Price
$1.29
Market Cap
$567.34M
Change (1 day)
-1.33%
Change (1 year)
-20.72%
Country
CN
Trade Zhejiang Starry Pharmaceutical Co.,Ltd. (603520)

Category

Stock price history for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520)
Highest end of day price: $1.30 on 2026-08-01

Lowest end of day price: $1.81 on 2016-03-01
Stock price history of Zhejiang Starry Pharmaceutical Co.,Ltd. from 2016 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 9.49%
2025 2.59%
2024 -35.49%
2023 -25.23%
2022 -60.98%
2021 -5.21%
2020 140.70%
2019 113.70%
2018 -9.58%
2017 -37.64%
2016 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$165.82 31.04%
DE
$37.61 25.11%
JP
$220.25 26.30%
CH
$21.28 17.65%
IN